Physician profile
Dara Wright Curtis
NPI 1851509400
$1,028.98
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $416 · 2022: $421 · 2023: $160 · 2024: $32.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $191.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $357.10 | 2021-2023 | |
| Avion Pharmaceuticals | $72.55 | 2021 | |
| Exeltis, USA INC. | $54.67 | 2021-2023 | Slynd |
| Organon LLC | $54.31 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $54.22 | 2021-2022 | |
| Daiichi Sankyo INC. | $52.61 | 2021 | |
| Hologic Sales and Service, LLC | $48.43 | 2021-2024 | Myosure Tissue Removal Device |
| Scynexis, INC. | $39.09 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $37.13 | 2022 | |
| Mission Pharmacal Company | $35.01 | 2023 | Citranatal |
| Mayne Pharma Commercial LLC | $31.02 | 2023 | |
| Myovant Sciences INC. | $28.73 | 2022 | |
| Evofem Biosciences, INC. | $28.62 | 2021-2022 | |
| Astellas Pharma US INC | $26.65 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.98 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $24.59 | 2022 | |
| Medtronic, INC. | $17.47 | 2022 | |
| Aspira Women'S Health INC | $15.25 | 2022 | |
| Bausch Health US, LLC | $14.90 | 2021 | |
| Currax Pharmaceuticals LLC | $11.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dara Curtis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.